STOCK TITAN

ImageneBio (IMA) Debt by Year

IMA NASDAQ

ImageneBio, Inc. held $94.5M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters ImageneBio, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $94.5M

Ticker history: IKNA became IMA (ImageneBio, Inc.) on . Earlier news and filings retain their original names and dates. View IKNA history.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IMA Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Long-Term DebtN/AN/AN/AN/AN/AN/A
Cash & Equivalents$94.5M+680.1%$12.1M-89.9%$119.9M+100.1%$59.9M-74.2%$232.2M+42.9%$162.5M

IMA Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$94.7M+62.4%$76.0M+106.9%$94.5M+680.1%$103.2M+128.3%$58.3M+31.7%$36.8M-30.4%$12.1M-89.9%$45.2M-62.7%$44.3M-37.5%$52.9M+80.2%$119.9M+100.1%$121.3M+80.8%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More ImageneBio, Inc. financials

Frequently Asked Questions

ImageneBio, Inc. held $94.5M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what ImageneBio, Inc. (IMA) reported on that line in every period on record.